Article info
PDFReview
Combined modality management of advanced cervical cancer including novel sensitizers
- Correspondence to Dr David SP Tan, Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore; david_sp_tan{at}nuhs.edu.sg
Citation
Combined modality management of advanced cervical cancer including novel sensitizers
Publication history
- Received September 27, 2021
- Accepted January 7, 2022
- First published March 7, 2022.
Online issue publication
March 08, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.